Corbus Pharmaceuticals Holdings, Inc. SEC filings CRBP
Corbus Pharmaceuticals Holdings, Inc. has 808 filings in SEC EDGAR's recent list, going back to Jan 10, 2014. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 7, 2026 | — |
| S-8 | Employee stock plan registration | Jun 17, 2026 | — |
| S-8 | Employee stock plan registration | May 29, 2026 | — |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| S-3 | Shelf registration | Mar 11, 2026 | — |
| 424B5 | Prospectus supplement | Nov 3, 2025 | — |
| 424B5 | Prospectus supplement | Oct 30, 2025 | — |
| S-8 | Employee stock plan registration | May 31, 2024 | — |
| 424B3 | Prospectus | Mar 20, 2024 | — |
| S-3 | Shelf registration | Mar 13, 2024 | — |
| 424B5 | Prospectus supplement | Feb 1, 2024 | — |
| S-3MEF | Filing | Jan 31, 2024 | — |
| 424B5 | Prospectus supplement | Jan 31, 2024 | — |
| 424B3 | Prospectus | Jan 29, 2024 | — |
| 424B3 | Prospectus | Jun 13, 2023 | — |
| S-3/A | Filing | Jun 12, 2023 | — |
| S-3 | Shelf registration | Jun 1, 2023 | — |
| S-8 | Employee stock plan registration | Mar 10, 2023 | — |
| S-8 | Employee stock plan registration | Mar 15, 2022 | — |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| 424B5 | Prospectus supplement | Aug 7, 2020 | — |
| 424B5 | Prospectus supplement | Aug 7, 2020 | — |
| 424B3 | Prospectus | May 4, 2020 | — |
| S-3/A | Filing | Apr 24, 2020 | — |
| S-3 | Shelf registration | Apr 7, 2020 | — |
| S-8 | Employee stock plan registration | Mar 17, 2020 | — |
| 424B5 | Prospectus supplement | Feb 10, 2020 | — |
| 424B5 | Prospectus supplement | Feb 6, 2020 | — |
| S-8 | Employee stock plan registration | Mar 12, 2019 | — |
| 424B5 | Prospectus supplement | Jan 28, 2019 | — |
| 424B5 | Prospectus supplement | Jan 24, 2019 | — |
| S-8 | Employee stock plan registration | Mar 16, 2018 | — |
| 424B3 | Prospectus | Jan 17, 2018 | — |
| S-3 | Shelf registration | Jan 5, 2018 | — |
| 424B5 | Prospectus supplement | Oct 25, 2017 | — |
| 424B5 | Prospectus supplement | Oct 23, 2017 | — |
| S-8 | Employee stock plan registration | Mar 9, 2017 | — |
| 424B5 | Prospectus supplement | Feb 28, 2017 | — |
| 424B5 | Prospectus supplement | Nov 23, 2016 | — |
| POS AM | Filing | Sep 8, 2016 | — |
| 424B5 | Prospectus supplement | Jun 13, 2016 | — |
| S-8 | Employee stock plan registration | Mar 28, 2016 | — |
| S-3 | Shelf registration | Nov 10, 2015 | — |
| 424B3 | Prospectus | Nov 10, 2015 | — |
| 424B3 | Prospectus | Aug 13, 2015 | — |
| 424B3 | Prospectus | May 13, 2015 | — |
| 424B3 | Prospectus | Apr 16, 2015 | — |
| 424B3 | Prospectus | Apr 6, 2015 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Mar 31, 2015 | — |
| S-8 | Employee stock plan registration | Feb 5, 2015 | — |
| S-8 | Employee stock plan registration | Nov 18, 2014 | — |
| 424B3 | Prospectus | Oct 7, 2014 | — |
| S-1/A | Amended registration statement | Oct 2, 2014 | — |
| S-1/A | Amended registration statement | Sep 30, 2014 | — |
| S-1 | Registration statement | Sep 3, 2014 | — |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRBP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Norwood, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1595097
- Former names
- SAV Acquisition Corp (until Jan 10, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.